Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02639676 · ClinicalTrials.gov registry record
Anti-Angiogenic Preeclampsia Milieu Impairs Infant Lung and Vascular Development
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 292
- Enrollment target
NCT02639676 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 292 participants.
The verdict
NCT02639676 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 292 participants
- Enrollment target
Study Summary
Pregnant mothers who develop high blood pressure and other vascular problems (preeclampsia) deliver babies with increased neonatal health problems, which include lung disease and vascular complications, later in life. Investigators will evaluate whether infants of mothers with preeclampsia have evidence for impaired development of the lungs and blood vessels.
Interventions
- OTHER Diffusion Lung Capacity (DLCO), Vascular Challenge, Video Imaging, Specimen Collections
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 292 participants |
| Start Date | 2016-02-11 |
| Est. Completion | 2020-11-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02639676
The ClinicalTrials.gov registry entry for NCT02639676 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 292 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diffusion Lung Capacity (DLCO), Vascular Challenge, Video Imaging, Specimen Collections is the first listed.
NCT02639676 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02639676 about?
NCT02639676 is a clinical study titled "Anti-Angiogenic Preeclampsia Milieu Impairs Infant Lung and Vascular Development". Pregnant mothers who develop high blood pressure and other vascular problems (preeclampsia) deliver babies with increased neonatal health problems, which include lung disease and vascular complications, later in life. Investigators will evaluate whether infants of mothers with preeclampsia have evid...
What is the current status of trial NCT02639676?
This trial is currently completed. The enrollment target is 292 participants. The study started on 2016-02-11. Estimated completion is 2020-11-17.
What interventions are being tested in trial NCT02639676?
The interventions under investigation include: Diffusion Lung Capacity (DLCO), Vascular Challenge, Video Imaging, Specimen Collections (OTHER).
Who is sponsoring clinical trial NCT02639676?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.